Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/PA/Erie

Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Erie, PA

Studies commonly pay $75 to $4,500 per completed study

88 clinical trials are currently recruiting participants within 30 miles of Erie. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

88studies recruiting

4+research centers nearby

5condition categories

Live from the NIH registry

Studies recruiting near Erie right now

Top 25 of 88 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Astellas Pharma Global Development, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06532279)

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer Phase 2, Phase 3 Interventional 1,912 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05174169)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06931340)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06876714)

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 272 participants sought

Erie Retina Research LLC — Erie, Pennsylvania (1.1 mi) · Sponsor: Novartis Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07441642)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04671667)

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

Pneumococcal Disease Phase 3 Interventional 3,230 participants sought

Allegheny Health and Wellness Pavilion — Erie, Pennsylvania (1.1 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT07629440)

E-Mindfulness Approaches for Living After Breast Cancer

Breast Cancer, Depression Phase 3 Interventional 402 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06748222)

A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

Functional Hypothalamic Amenorrhea (FHA) Phase 2 Interventional 34 participants sought

OBGYN Associates of Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Regeneron Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07235917)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought

Adverum Clinical Site 181 — Erie, Pennsylvania (1.1 mi) · Sponsor: Adverum Biotechnologies, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07482176)

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Amblyopia Phase 3 Interventional 238 participants sought

Pediatric Ophthalmology of Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Jaeb Center for Health Research

See eligibility & contact on ClinicalTrials.gov (NCT06380517)

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

Macular Edema Secondary to Inflammation Phase 3 Interventional 600 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Kodiak Sciences Inc

See eligibility & contact on ClinicalTrials.gov (NCT06990399)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04402788)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 2, Phase 3 Interventional 224 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06203600)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06498635)

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy Phase 2 Interventional 100 participants sought

Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Vantage Biosciences Ltd

See eligibility & contact on ClinicalTrials.gov (NCT06770933)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05327686)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought

Anthos Investigative Site 9924 — Westfield, New York (29.0 mi) · Sponsor: Anthos Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05712200)

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC) Phase 3 Interventional 1,040 participants sought

UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06661720)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought

Clinical Trial Site — Westfield, New York (29.0 mi) · Sponsor: Alnylam Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07181109)

Actively enrolling

Studies you may be able to join near Erie

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Erie

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Square-1 Clinical Research

2221-A Ebco Dr, Erie, PA 16506

(814) 838-8724

Website

Erie Retina Research

★ 4.8

2005 W 8th St, Erie, PA 16505

(814) 200-9152

Website

"Dr. Almeida is always awesome!"

— Joe Ropelewski, 5★

Susan Hirt Hagen Center for Community Outreach, Research, and Evaluation (CORE)

★ 5.0

5343 Station Rd, Erie, PA 16510

(814) 898-6297

Website

"Great tour today! Props to Hannah, our guide"

— Jeanie Sing, 5★

Great Lakes Medical Research

138 E Main St, Westfield, NY 14787

(716) 326-4890

Website

Clinical trials in Erie: what's recruiting

The Erie area currently has 88 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Erie, the most active research areas are:

Cancer & Oncology15 studies
Heart & Vascular2 studies
Liver & Kidney2 studies
Brain & Mental Health1 studies
Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Erie, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Erie

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Erie participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Erie?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Erie safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Erie?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Erie typically complete one or two studies per year.

Paid clinical trials near Erie

Other metros within reach

Youngstown, OH87 Buffalo, NY513 Pittsburgh, PA1,237 Cleveland, OH1,409 Akron, OH394 Canton, OH307 Lorain, OH1,304 Rochester, NY459

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Erie Bladder Issues Due To Spinal Cord Injury in Erie All conditions

More of PA

Philadelphia2,175 Pittsburgh1,237 York453 Lancaster434 Harrisburg405 Reading280 Allentown236 Scranton100

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts